134 related articles for article (PubMed ID: 2170968)
1. Variable expression of Epstein-Barr virus genome as demonstrated by in situ hybridization in central nervous system lymphomas in immunocompromised patients.
Bashir RM; Hochberg FH; Harris NL; Purtilo D
Mod Pathol; 1990 Jul; 3(4):429-34. PubMed ID: 2170968
[TBL] [Abstract][Full Text] [Related]
2. Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus.
Chang KL; Flaris N; Hickey WF; Johnson RM; Meyer JS; Weiss LM
Mod Pathol; 1993 Jul; 6(4):427-32. PubMed ID: 8415586
[TBL] [Abstract][Full Text] [Related]
3. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
Borisch-Chappuis B; Nezelof C; Müller H; Müller-Hermelink HK
Am J Pathol; 1990 Apr; 136(4):751-8. PubMed ID: 1691592
[TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization.
Bashir RM; Harris NL; Hochberg FH; Singer RM
Neurology; 1989 Jun; 39(6):813-7. PubMed ID: 2471116
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and AIDS-related primary central nervous system lymphoma. Viral detection by immunohistochemistry, RNA in situ hybridization, and polymerase chain reaction.
Guterman KS; Hair LS; Morgello S
Clin Neuropathol; 1996; 15(2):79-86. PubMed ID: 8925601
[TBL] [Abstract][Full Text] [Related]
7. Detection of EBER nuclear RNA in T-cell lymphomas involving the skin--an in situ hybridization study.
Park CK; Ko YH
Br J Dermatol; 1996 Mar; 134(3):488-93. PubMed ID: 8731674
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of immunohistochemistry and in situ hybridization techniques in diseases caused by or associated with Epstein-Barr virus].
Audouin J; Prevot S; Brouland JP; Molina T; Le Tourneau A; Diebold J
Arch Anat Cytol Pathol; 1992; 40(2-3):95-104. PubMed ID: 1333177
[TBL] [Abstract][Full Text] [Related]
9. In situ hybridization for the detection of Epstein-Barr virus in central nervous system lymphomas.
Nakhleh RE; Manivel JC; Copenhaver CM; Sung JH; Strickler JG
Cancer; 1991 Jan; 67(2):444-8. PubMed ID: 1845947
[TBL] [Abstract][Full Text] [Related]
10. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of BCL-2, BCL-X, and BAX in primary central nervous system lymphomas that occur in immunosuppressed patients.
Camilleri-Broët S; Camparo P; Mokhtari K; Hoang-Xuan KH; Martin A; Arborio M; Hauw JJ; Raphaël M
Mod Pathol; 2000 Feb; 13(2):158-65. PubMed ID: 10697273
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.
Hamilton-Dutoit SJ; Pallesen G; Franzmann MB; Karkov J; Black F; Skinhøj P; Pedersen C
Am J Pathol; 1991 Jan; 138(1):149-63. PubMed ID: 1846263
[TBL] [Abstract][Full Text] [Related]
13. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
15. Latent Epstein-Barr virus infection demonstrated in low-grade leiomyosarcomas of adults with acquired immunodeficiency syndrome, but not in adjacent Kaposi's lesion or smooth muscle tumors in immunocompetent patients.
Boman F; Gultekin H; Dickman PS
Arch Pathol Lab Med; 1997 Aug; 121(8):834-8. PubMed ID: 9278611
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
18. Detection of Epstein-Barr virus genomes by in situ DNA hybridization with a terminally biotin-labeled synthetic oligonucleotide probe from the EBV Not I and Pst I tandem repeat regions.
Montone KT; Budgeon LR; Brigati DJ
Mod Pathol; 1990 Jan; 3(1):89-96. PubMed ID: 2155420
[TBL] [Abstract][Full Text] [Related]
19. An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents.
Hollingsworth HC; Peiper SC; Weiss LM; Raffeld M; Jaffe ES
Arch Pathol Lab Med; 1994 Feb; 118(2):134-40. PubMed ID: 8311651
[TBL] [Abstract][Full Text] [Related]
20. Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
Pizzo PA; Chattopadhyay SK; Magrath IT; Del Giacco E; Sherrick D; Gray T
Cancer Res; 1981 Aug; 41(8):3165-71. PubMed ID: 6265077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
